SI2111401T1 - 4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
- Google Patents
4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
Info
Publication number
SI2111401T1
SI2111401T1SI200730558TSI200730558TSI2111401T1SI 2111401 T1SI2111401 T1SI 2111401T1SI 200730558 TSI200730558 TSI 200730558TSI 200730558 TSI200730558 TSI 200730558TSI 2111401 T1SI2111401 T1SI 2111401T1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LlcfiledCriticalBayer Healthcare Llc
Priority claimed from PCT/US2007/088365external-prioritypatent/WO2008079968A1/en
Publication of SI2111401T1publicationCriticalpatent/SI2111401T1/en
SI200730558T2006-12-202007-12-204-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
SI2111401T1
(en)
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1h-pyrazol-5-yl}carbamoyl)-amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro- 2-methylpropan-2-yl)isoxazol-3-yl)urea as raf kinase modulator in the treatment of cancer diseases raf 1-(3-(67--4- ))-3-(5-(111--2--2-)-3-)
2-amino-1-((phosphonooxy)methyl)-3-(3-((4-((2-pyridinyloxy)methyl)phenyl)methyl)-5-isoxazolyl)-pyridinium and pharmaceutical composition comprising the same
2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, medicaments comprising them and use thereof
N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer